Global Biologics CMO Data features over 450 worldwide contract manufacturing organizations engaged in the contract services of manufacturing of biologics products including antibodies, vaccines, recombinant products, cell & gene therapy products among others, starting from cell-line development to fill & finish.
The data provides detailed insights that are available nowhere in the market with the goal of assisting market players in advancing their priorities and investments, as well as accessing the competitive landscape. The data and companies included in this tracker is covered across 4 regions- Asia, Europe, North America, Rest of the World.
The data is captured around 25 vital metrics including biologics manufacturer’s name, location, service offering capabilities, scale of manufacturing, technology platforms, products and subproducts manufactured, current & completed projects of CMOs, facility name, location, establishment year, facility size & capacity, annual production, batch size, bioprocessing equipment, bioreactors, expression system, manufacturing process type, regulatory compliance & certifications, sponsors & collaborations, future plans of CMOs and many other parameters. Complete list of parameters is provided in the following section.
Based on the data, North America has the largest market share of 31% for Biologics focused CMOs. The second largest market with highest numbers of CMOs and biomanufacturing facility is Europe with almost 30% followed by Asia at 28% and rest of the countries with 11%.
The data is underpinned by user-friendly visuals to allow users to filter through within all the parameters to obtain any specific data such as CMOs by country, CMOs name, product manufacturing type, scale of manufacturing, regulatory compliance, bioreactor capacity & types, service offerings, facility size, expression system, manufacturing process mode, analytical and bioprocessing equipment, collaborators, suppliers.